Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Fatal SARS-CoV-2 infection in a renal transplant recipient
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
title
Fatal SARS-CoV-2 infection in a renal transplant recipient
Creator
Ali, ·
Demir, Erol
Garayeva, Nurana
Oto, Akin
Safak, Seda
Ucar, Riza
Yazici, Halil
Arif, ·
Dirim, Ahmet
Alibeyoglu, Medet
Alpay, ·
Aydin Turkmen, ·
Cagatay, Atahan
Gunseli Orhun, ·
Ozgur, ·
source
Medline; PMC
abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV 2) caused a pandemic that first discovered in Wuhan, China. While 10% of the patients have asymptomatic infection, 15–20% have lung involvement, 5–10% have multiple organ failure, and macrophage activation syndrome. Chronic respiratory diseases, diabetes mellitus, hypertension, and cancer are risk factors for mortality. Prognosis or optimal treatment strategy for renal transplant recipients in SARS-CoV-2 infection is still unknown. Besides fatal cases, there were also milder case reports. In addition, COVID-19 treatment and the maintenance immunosuppression strategy is still under debate. Antiviral therapies and drug interactions are special topics for these patients. To the best of our knowledge, favipiravir and anti-cytokine treatments have not been previously reported in a kidney transplant recipient with SARS-CoV-2 infection before. We report a case of SARS-CoV-2 infection in a kidney transplant recipient with fatal outcomes.
has issue date
2020-06-20
(
xsd:dateTime
)
bibo:doi
10.1007/s13730-020-00496-4
bibo:pmid
32564306
has license
no-cc
sha1sum (hex)
915059bd7ae23cd57a38e4af6bf24592e8f3a8a3
schema:url
https://doi.org/10.1007/s13730-020-00496-4
resource representing a document's title
Fatal SARS-CoV-2 infection in a renal transplant recipient
has PubMed Central identifier
PMC7305930
has PubMed identifier
32564306
schema:publication
CEN Case Rep
resource representing a document's body
covid:915059bd7ae23cd57a38e4af6bf24592e8f3a8a3#body_text
is
schema:about
of
named entity 'Antiviral'
named entity 'asymptomatic infection'
named entity 'infection'
named entity 'FATAL'
named entity 'REPORT'
named entity 'kidney transplant'
named entity 'diabetes mellitus'
named entity 'pandemic'
named entity 'respiratory diseases'
named entity 'case reports'
named entity 'SARS-CoV-2'
named entity 'patients'
named entity 'case'
named entity 'renal transplant'
named entity 'case reports'
named entity 'diabetes mellitus'
named entity 'infection'
named entity 'China'
named entity 'kidney transplant'
named entity 'severe acute respiratory syndrome coronavirus 2'
named entity 'SARS-CoV-2'
named entity 'nasopharyngeal swab'
named entity 'intravenous'
named entity 'troponin'
named entity 'supportive treatment'
named entity 'SARS-CoV-2'
named entity 'kidney transplant'
named entity 'infection'
named entity 'tocilizumab'
named entity 'targeted therapies'
named entity 'intubated'
named entity 'kidney transplant'
named entity 'lung'
named entity 'cytokine'
named entity 'kidney transplant'
named entity 'calcineurin inhibitor'
named entity 'COVID'
named entity 'high-sensitivity C-reactive protein'
named entity 'hypoxemia'
named entity 'refractory'
named entity 'false-negative'
named entity 'triglyceride'
named entity 'hydroxychloroquine'
named entity 'PCR'
named entity 'broad-spectrum antibiotics'
named entity 'cough'
named entity 'meropenem'
named entity 'diabetes mellitus'
named entity 'antiproliferative'
named entity 'severe acute respiratory syndrome coronavirus'
named entity 'PCR test'
named entity 'COVID'
named entity 'Streptococcus'
named entity 'N-terminal'
named entity 'Hypoxemia'
named entity 'favipiravir'
named entity 'tachypneic'
named entity 'serum ferritin'
named entity 'fever'
named entity 'clinical characteristics'
named entity 'infection'
named entity 'infection'
named entity 'emergency clinic'
named entity 'IVIG'
named entity 'COVID'
named entity 'SARS-CoV-2'
named entity 'Middle East respiratory syndrome'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 5
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software